Clinical Trials in Swidnica, Poland
2 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 2
A Dose Response Study to Evaluate the Efficacy and Safety of Oral AP1189 Administered in Disease-Modifying Anti-Rheumatic Drug (DMARD) naïve Participants Participants With Early Rheumatoid Arthritis
Rheumatoid Arthritis (RA)
SynAct Pharma Aps240 enrolled11 locationsNCT06671054
Recruiting
Phase 2
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Moderately to Severely Active Crohn Disease
Abivax S.A.212 enrolled149 locationsNCT06456593